KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lam Research (LRCX) Common Equity (2016 - 2026)

Lam Research has reported Common Equity over the past 18 years, most recently at $10.6 billion for Q1 2026.

  • For Q1 2026, Common Equity rose 11.29% year-over-year to $10.6 billion; the TTM value through Mar 2026 reached $10.6 billion, up 11.29%, while the annual FY2025 figure was $9.9 billion, 15.48% up from the prior year.
  • Common Equity for Q1 2026 was $10.6 billion at Lam Research, up from $10.1 billion in the prior quarter.
  • Over five years, Common Equity peaked at $10.6 billion in Q1 2026 and troughed at $6.0 billion in Q1 2022.
  • A 5-year average of $8.5 billion and a median of $8.4 billion in 2023 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: soared 39.51% in 2023 and later fell 4.58% in 2024.
  • Year by year, Common Equity stood at $8.3 billion in 2022, then dropped by 0.99% to $8.2 billion in 2023, then grew by 7.12% to $8.8 billion in 2024, then rose by 15.18% to $10.1 billion in 2025, then grew by 4.33% to $10.6 billion in 2026.
  • Business Quant data shows Common Equity for LRCX at $10.6 billion in Q1 2026, $10.1 billion in Q4 2025, and $10.2 billion in Q3 2025.